Cargando…
Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections
Vaginal infections affect 70% of women during their lifetimes and account for millions of annual doctors’ visits. These infections are predominantly represented by vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV). Although standard antimicrobial agents remain the major strategy for the pr...
Autores principales: | Gaziano, Roberta, Sabbatini, Samuele, Roselletti, Elena, Perito, Stefano, Monari, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186379/ https://www.ncbi.nlm.nih.gov/pubmed/32373104 http://dx.doi.org/10.3389/fmicb.2020.00718 |
Ejemplares similares
-
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019) -
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis
por: Pericolini, Eva, et al.
Publicado: (2016) -
Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
por: Sabbatini, Samuele, et al.
Publicado: (2018) -
Apoptosis of vaginal epithelial cells in clinical samples from women with diagnosed bacterial vaginosis
por: Roselletti, Elena, et al.
Publicado: (2020) -
A Role for Yeast/Pseudohyphal Cells of Candida albicans in the Correlated Expression of NLRP3 Inflammasome Inducers in Women With Acute Vulvovaginal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019)